HackerNews Summary (2023-06-04 06AM)

Source: Ask HN: Struggling with Productivity and Procrastination

Summary
Struggling with productivity and organization, procrastination, and feeling guilty. Possible ADHD or dopamine addiction. Looking for advice on improving focus and productivity to achieve goals.

Fact

🧠 Take breaks every 25-30 minutes to avoid burnout and increase productivity.

📅 Make a daily to-do list and prioritize tasks based on importance and deadline.

💬 Talk to a healthcare professional about potential ADHD or other underlying issues.

🚫 Remove temptations and distractions by turning off notifications and finding a quiet work environment.

👥 Find an accountability partner or join a support group to help stay motivated and on track.

---

Source: Rob Henderson’s Newsletter

Summary
Social status is a more powerful motivator than money for many people. It is defined as a claim to social esteem in terms of positive or negative privileges and is a ranking of people based on attributes, actions, occupations, or group affiliations. Our brains spend about 50% of their time mind wandering, which often focuses on social evaluations, making status an important consideration. Evolutionary psychology suggests that natural selection has produced mental adaptations that make social status an essential motivator.

Fact
💰 Money is not the only motivator, and social status is often more important.
💭 Our brains spend about 50% of their time mind wandering, focusing on social evaluations of ourselves and others.
🦍 Evolutionary psychology suggests natural selection produced mental adaptations that make social status an essential motivator.

---

Source: Lung cancer pill cuts risk of death by half, says ‘thrilling’ study

Summary
A daily pill called osimertinib has been found to cut the risk of dying from lung cancer by 51%, according to a decade-long study involving patients from 26 countries. The study, which looked at the pill’s effect on non-small cell lung cancer patients who had an EGFR mutation, found that treatment with osimertinib after surgery significantly lowered the risk of death.

Facts

💊 A daily pill called osimertinib has been found to cut the risk of dying from lung cancer by 51%.

🌍 The drug was tested in a global study involving patients from 26 countries.

🧬 The study looked at non-small cell lung cancer patients who had an EGFR mutation.

👩‍🦱👨‍🦱 EGFR mutation is found in about a quarter of global lung cancer cases, and as many as 40% of cases in Asia. It’s also more common in women and people who have never smoked.

🩺 The trial involved patients aged between 30 and 86.

🔬 The drug, also known as Tagrisso, is made by AstraZeneca.

---